News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004
Mydecine Innovations Group
Tryp Therapeutics to Present at the Psych Investor Summit
Tryp Therapeutics
BetterLife Secures Mitacs Funding in Collaboration with Carleton University Research Team for TD-0148A Preclinical Depression Studies
BetterLife Pharma
COMPASS Pathways Becomes Founding Supporter of the British Neuroscience Association’s Inaugural Scholars Programme
Compass Pathways
Nova Mentis Autism Clinical Study Approved by Canadian Institutional Review Board
Nova Mentis Life Science
MindMed Appoints MGH Psychiatrist-in-Chief Dr. Maurizio Fava to Scientific Advisory Board
Mind Medicine (MindMed)
Mydecine to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28th
Mydecine Innovations Group
Roth Capital Partners Initiates Coverage on Mydecine, With Buy Rating And C$3 Price Target
Mydecine Innovations Group
Red Light Holland to Partner with Leading Fresh and Dried Mushroom Producers on East Coast Facility
Red Light Holland
Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third Wave
Entheon Biomedical
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.